Cited by 263Alzheimer's disease research and treatmentsProtein Kinase Regulation and GTPase SignalingNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β

Takashima, Akihiko, Noguchi, Kaori, Michel, Gilles, Mercken, Marc, Hoshi, Minako, Ishiguro, Koichi, Imahori, Kazutomo·1996·Neuroscience Letters

DOI 10.1016/0304-3940(95)12257-5

Open this paper in CoChat — free account

Abstract

Exposure of rat hippocampal neurons to the peptide amyloid beta (A beta) (25-35) as well as A beta (1-40) peptides enhances phosphorylation of tau to a paired helical filament (PHF)-state through activation of tau protein kinase I (TPK I)/glycogen synthase kinase-3 beta (GSK-3 beta) [Busciglio, J., Lorenzo, A., Yeh, J. and Yankner, B.A., Neuron, 14 (1995) 879-888; Takashima, A., Ishiguro, K., Noguchi, K., Michel, G., Hoshi, M., Sato, K., Takahashi, M., Hoshino, T., Uchida, T. and Imahori, K., Neurosci. Meeting Abstr., 671 (1995) 17]. In order to examine the effects of A beta treatment on intracellular signaling mechanism, we have investigated the role of phosphatidyl inositol-3 (PI-3) kinase in the phosphorylation of tau. A beta (25-35) exposure induced an inactivation of PI-3 kinase and an activation of TPK I/GSK-3 beta in rat hippocampal culture. Wortmannin, an inhibitor of PI-3 kinase, also activated TPK I/GSK-3 beta, leading to an enhancement of tau phosphorylation and neuronal death in hippocampal culture. These results suggest that A beta (25-35) inhibition of PI-3 kinase results in the activation of TPK I/GSK-3 beta, the phosphorylation of tau, and resultant neuronal death in rat hippocampal neurons.

Integrity signals

Registry

Crossref · 10.1016/0304-3940(95)12257-5

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,393
Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses
Arcaro, A., & Wymann, M. P. (1993) · Biochemical Journal · doi:10.1042/bj2960297 · Cited by 1,138
Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595
Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B
Welsh, G. I., & Proud, C. G. (1993) · Biochemical Journal · doi:10.1042/bj2940625 · Cited by 397
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Takashima, A., Noguchi, K., Sato, K., Hoshino, T., & Imahori, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7789 · Cited by 385
Self-citation

Show all 18 references

Sorted by citations

Items 201–263 of 263

Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles
Nwadiugwu, M. C., Onwuekwe, I. O., Ezeanolue, E. E., & Deng, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052646 · Cited by 9
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
Molecular cloning and expression analysis of human glycogen synthase kinase-3α promoter
Lee, C., Chan, J. Y.-C., Lau, K., Lee, C. W., Miller, C. C. J., Anderton, B. H., & Shaw, P. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00238-2 · Cited by 8
Developing BACE-1 inhibitors for FXS
Westmark, C. J., Berry‐Kravis, E., Ikonomidou, C., Yin, J. C. P., & Puglielli, L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00077 · Cited by 8
Development of a Cellular Tau Enzyme-Linked Immunosorbent Assay Method for Screening GSK-3β Inhibitors
Cho, G., Noh, M., Kang, B. Y., Ku, I.-W., Park, J., Hong, Y., Kim, M., & Kim, S. H. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0343 · Cited by 7
Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons
Ploia, C., Sclip, A., Colombo, A. V., Repici, M., Gardoni, F., Luca, M. D., Forloni, G., Antoniou, X., & Borsello, T. (2010) · Pharmaceuticals · doi:10.3390/ph3010042 · Cited by 7
Severe Diffuse Axon Injury in Chronic Alcoholic Rat Medulla Oblongata Following a Concussion Blow
Luo, J., Chen, G., Wei, L., Qian, H., Lai, X., Wang, D., Lv, J., & Yu, X. (2014) · Alcohol and Alcoholism · doi:10.1093/alcalc/agu009 · Cited by 7
Functional neuroanatomy and disorders of cognition
Nakhate, K. T., Borkar, C. D., & Bharne, A. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819445-4.00002-3 · Cited by 6
Correlation between survivin polymorphism and acute leukemia of children
Li, W.-X., Li, Y., & Lin, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5740 · Cited by 6
Links Between Amyloid and Tau Biology in Alzheimer’s Disease and Their Cholinergic Aspects
Siegel, G. J., Chauhan, N. B., & Karczma, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-46526-5_10 · Cited by 6
Polypeptide and Protein Aggregates with Neurotoxic Properties in Neurodegenerative Disorders: Emphasis on β-Amyloid-Induced Dysfunction of Receptor-Mediated Signal Transduction Pathways
Verdier, Y., & Penke, B. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269208 · Cited by 6
Bioinformatic analysis of hippocampal histopathology in Alzheimer’s disease and the therapeutic effects of active components of traditional Chinese medicine
Zhiyan, C., Min, Z., Yida, D., He, C., Hu, X., Yutong, L., Huan, W., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1424803 · Cited by 5
Alzheimer’s Disease and Diabetes
Brent, D. A., Gary, L., Aboud, Z., & Gordon, W. (2013) · InTech eBooks · doi:10.5772/54913 · Cited by 6
Beyond Secretases
Medda, F., Smith, B. E., Gokhale, V. M., Shaw, A. Y., Dunckley, T. L., & Hulme, C. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00005-3 · Cited by 5
Targeting glycogen synthase kinase-3 in Alzheimer's disease
Huang, H., O’Brien, W. T., & Klein, P. S. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.10.020 · Cited by 5
The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease
Ma, J., Liu, Y., Lu, D., & Sun, Q. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110754 · Cited by 5
Modulating Role of TTR in Aβ Toxicity, from Health to Disease
Cardoso, I., Santos, L. M., & Alemi, M. (2016) · InTech eBooks · doi:10.5772/63194 · Cited by 7
The promising role of bioactive congeners present in Cassytha filiformis in Alzheimer's disease: An explicative review
Khabiya, R., Karati, D., Dwivedi, S., Dwivedi, A., & Mukherjee, S. (2024) · Brain Disorders · doi:10.1016/j.dscb.2024.100125 · Cited by 4
Salivary mitochondrial DNA is associated with biomarkers of Alzheimer’s disease in cognitively normal older adults
Cantero-Lorente, J. L., Atienza, M., Podlesniy, P., Puigròs, M., & Trullás, R. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03589-9 · Cited by 3
Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment
Tripathi, S., Sharma, Y., & Kumar, D. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665348075241121071614 · Cited by 3
Neurodegenerative Diseases and Axonal Transport
Goldstein, L. S. B., & Das, U. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00012-2 · Cited by 3
Wnt Signaling Roles on the Structure and Function of the Central Synapses: Involvement in Alzheimer’s Disease
Nibaldo, C., & Varela‐Nallar, L. (2013) · InTech eBooks · doi:10.5772/54606 · Cited by 2
6‐Ethyl‐N,N′‐bis(3‐hydroxyphenyl)[1,3,5]triazine‐2,4‐diamine (RS‐0466) Enhances the Protective Effect of Brain‐Derived Neurotrophic Factor on Amyloid β‐Induced Cytotoxicity in Cortical Neurones
Kubo, T., Nishimura, S., Murasugi, T., Kaneko, I., Meguro, M., Marumoto, S., Kogen, H., Koyama, K., Oda, T., & Nakagami, Y. (2003) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2003.pto930603.x · Cited by 2
Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models
Faldini, E., Ahmed, T., Buée, L., Blum, D. L., & Balschun, D. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0813-4 · Cited by 3
Memory formation in old age requires GSK-3β
Koike, R., Takaichi, Y., Soeda, Y., & Takashima, A. (2021) · Aging Brain · doi:10.1016/j.nbas.2021.100022 · Cited by 2
Self-citation
Exploring the Protective Effects of Two Alkaloids 1 and 2 from Aspergillus terreus C23–3 on Neuronal Cells by Combining Bioinformatics Prediction and Experimental Verification
Chen, M., Tang, G., Zhang, Y., & Qian, Z. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00739 · Cited by 1
Single‐cell analysis reveals neuroprotective histone deacetylase inhibitor pathways
Peyton, M., Jury, N., Liu, J., Beimfohr, C., Sunil, C., Brooks, S., Zhang, P., McCabe, S., Richardson, T. I., Huang, K., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71108 · Cited by 1
Genetic Risk Factors: Their Function and Comorbidities in Alzheimer′s Disease
Hiltunen, M. O., Bertram, L., & Saunders, A. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/925362 · Cited by 1
Diet, Abeta Oligomers and Defective Insulin and Neurotrophic Factor Signaling in Alzheimer’s Disease
Cole, G. M., Ma, Q., Yang, F., Deshpande, A. M., Ubeda, O. J., & Frautschy, S. A. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0_11 · Cited by 1
Serotonin receptors - a potential target for the treatment of Alzheimer’s disease
Eremin, D. V., Kondaurova, E. M., Rodnyy, A. Y., Molobekova, K. A., Kudlay, D. A., & Naumenko, V. S. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523120059 · Cited by 1
Tauopathy and Brain Aging
Takashima, A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_5 · Cited by 1
Self-citation
The Role of HIV-1 Proteins in Alzheimer's Disease Pathology
Giunta, B. N. (2011) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Linking Aβ and tau in the amyloid cascade through the intersection of their proteostasis networksPreprint
Lim, C. M., Hardy, J., & Vendruscolo, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646065 · Cited by 1
Analysis of Reelin function in the molecular mechanisms underlying Alzheimer’s disease
Rossi, D. P. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Regulation of neuritogenesis in neuroblastoma cells by components of the WNT signalling pathway.
Orme, M. H. (2002) · OpenGrey (Institut de l'Information Scientifique et Technique)
Lítio e expressão gênica: implicações para a doença de Alzheimer.
Mendes, C. T. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2008.tde-10032009-113854
PTEN and Akt signalling in Alzheimer´s disease
Rickle, A. (2005) · Figshare
Other Mechanisms of Neurodegeneration
Boziki, M. K., Papaliagkas, V., & Tsolaki, M. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch9
In vitro modelling of tau phosphorylating kinases : emphasis of Cdk5
Jämsä, A. (2007) · Figshare
Flavonoids as Modulators of Amyloid Precursor Protein Metabolism and Alzheimer Disease Pathology
Rezai-Zadeh, K. P. (2008) · Digital Commons - University of South Florida (University of South Florida)
Animal Models of Tauopathy
Duff, K., Krishnamurthy, P., Planel, E., & Hutton, M. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_13
Characterising transgenic APP mutation mouse models of amyloid pathology for use in preclinical immunotherapy
Hvoslef‐Eide, M. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Opposite effects of lithium and valproic acid on trophic deprivation-induced GSK-3(Beta) activation, c-Jun expression and neuronal cell death
Jin, N. Y. (2004) · RIT Scholar Works (Rochester Institute of Technology)
Global Approaches to Understanding Protein Kinase Functions
Gorman, J. L., & Woodgett, J. R. (2015) · Wiley eBooks · doi:10.1002/9783527683031.ch1
Synaptic elimination and the complement system in Alzhaimer's disease
Daborg, J. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
[Regulation of phosphorylation of tau by insulin and Ca2+ signals].
Yamamoto, H. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.125.129
Potentiation of Cellular Defense Capacity by Phytochemicals Activating NF-E2-Related Factor 2 for the Prevention and/or Treatment of Alzheimer’s Disease
Park, G. H., & Jang, J. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_21
Regulation of Amyloid Precursor Protein Processing by Lithium
Sun, X., & Takashima, A. (2004) · CRC Press eBooks · doi:10.1201/9780203492185.ch10
Self-citation
THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
Cloyd, R. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.271
Chapter 4. Transgenic Mice Overexpressing GSK-3β as Animal Models for Alzheimer's Disease
Hernández, F. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732758-00052
Scouting Biomarkers for Alzheimer’s Disease via Network Analysis of Exosome Proteomics Data
Sagonas, A., Apostolakou, A. E., Litou, Z. I., Antonelou, M. H., & Iconomidou, V. A. (2025) · BioMedInformatics · doi:10.3390/biomedinformatics5020019
Glycogen Synthase Kinase-3β: A Key Player in Alzheimer's Disease Pathogenesis and Therapeutic Targeting
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Current Signal Transduction Therapy · doi:10.2174/0115743624366360250630070154
In-Silico Investigational Study of Pyrido-acridine Congener Amphimedine against Alzheimer’s Disease
Karati, D. (2025) · Asian Journal of Pharmaceutical Research · doi:10.52711/2231-5691.2025.00056
Aß Toxicity in Alzheimer’s Disease
Klein, W. L. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_1 · Cited by 14
INVESTIGATIONS INTO MODULATION OF BRAIN OXIDATIVE STRESS BY VARIOUS INTERVENTIONS
Harris, J. L. (2012) · UKnowledge (University of Kentucky)
Validation préclinique de l'efficacité de l'ANAVEX2-73 dans des modèles transgénique et non transgénique de la maladie d'Alzheimer
Lahmy, V. (2014) · theses.fr (ABES) · doi:10.70675/23744d67zb26bz4a32zadbfz3931ecca70f5
Modulation of Oncogenic KRAS Signaling by Branched Actin-driven Cell Membrane ProtrusionsPreprint
Gihana, G. M., Bhatt, K., Chang, B.-J., Murali, V. S., Zhou, F., Noh, J., Ravishankar, R., Borges, H., Lin, J., Oceguera, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.09.717047
Unlocking the potential of GSK-3β inhibitors in neurodegenerative disease prognosis: insights from glucagon-like peptide-1 receptor agonist effects
Khalifa, A. S., Ibrahim, A., Khalid, S., Abdelfattah, A. M., Bakkar, N. Z., Elrewiny, M. A., & El-Yazbi, A. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00021-8
Microbial enzymes for biorefinery processes and application of microbial fermentation technologies
Kaur, B., Kuhad, R. C., & Sharma, K. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27747-4.00008-5
The Adult Neurogenesis Theory of Alzheimer’s Disease Predicts Where Tauopathy Develops in the Brain
Abbate, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198776
BindingDB Entry 50038906: The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.
BindingDB (2012) · UC San Diego · doi:10.7270/q2n87bqg
BindingDB Entry 50015113: Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease.
BindingDB (2023) · UC San Diego · doi:10.7270/q26d5xwb
BindingDB Entry 50032642: Discovery of novel GSK-3ß inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening.
BindingDB (2011) · UC San Diego · doi:10.7270/q2db8230

Authors: Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K.
Corresponding author: Takashima, Akihiko
ORCID: Takashima, Akihiko
Hoshi, Minako
Venue: Neuroscience Letters
Publisher: Elsevier BV
Published: 1996-01
Volume: 203
Issue: 1
Pages: 33-36
ISSN: 0304-3940 (ISSN-L)
DOI: 10.1016/0304-3940(95)12257-5
OpenAlex: W1986537744
Cited by: 260
References: 18
Citations by year: 2026: 5 · 2025: 9 · 2024: 5 · 2023: 9 · 2022: 4 · 2021: 9 · 2020: 5 · 2019: 11 · 2018: 12 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 15 · 2013: 13 · 2012: 13
FWCI: 3.21
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience Letters (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: amyloid beta 25-35, Aβ40, phosphatidylinositol 3-kinase, glycogen synthase kinase-3β, tau phosphorylation, paired helical filaments, hippocampal neurons, neuronal cell death, wortmannin, Alzheimer's disease
MeSH terms: Wortmannin, Alzheimer Disease, Androstadienes, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Inhibitors, Glycogen Synthase, Hippocampus, Phosphotransferases, Amyloid beta-Protein Precursor, tau Proteins, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Exposure of rat hippocampal neurons to amyloid β peptide (25–35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks